Login

Union Square Ventures is a venture capital firm|Brad Burnham,Partner,Union Square Ventures 00:10:00

Share On Facebook Share On Twitter

He started working in information technology with AT&T in 1979

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Fermentalg in the Running for Europe 1’s Trophées de l'Avenir for Environmental Excellence | Philippe Lavielle, CEO , FERMENTALG SA.
00:10:00
Kane Brenan Analyzes 2018 Investment Outlook and Its Implications for Major Asset Classes in Insightful Presentation
00:10:00
Caliber Mining's Ryan King Discusses Q2 Financials and Hub-and-Spoke Success in Nicaragua
00:10:00
Ardea Resources: Kalgoorlie Nickel Project Update
00:10:00
Billionaire Hedge Fund Manager David Tepper to Return Outside Capital and Transition Appaloosa Management to Family Office, Reports Bloomberg
00:10:00
As Bitcoin rebounds after a tumultuous year for the crypto industry, Galaxy Digital Founder & CEO Mike Novogratz remains optimistic.
00:10:00
Analyzing YTL Corporation's Impressive Quarter: Profit Growth Amidst Diverse Business Strategies | Francis yeoh , Chairman, YTL Corporation Bhd.
00:10:00
Venture capital firm on a mission to diversify the face of wealth|Diana Murakhovskaya,Co-Founder and General Partner,The Artemis Fund
00:10:00
Vanadium Resources: Advancing the Tier-One Steelpoort Vanadium Project Towards Investment Decision
00:10:00
CEO Alan Trefler positions Pegasystems for the long game in customer-centric innovation and sustainable growth.|Alan Trefler is the Founder and CEO of Pegasystems Inc.,
00:10:00
On Clerking for Judge Wisdom|James P. Fogelman,Partner,Gibson Dunn
00:10:00
Philippines' Energy Transition: A Call for National Collaboration | Eric Francia, CEO, Acen Corp.

© 2026 Nehu